Drugs don’t work if people can’t afford them.

New Report: Illinois Could Save $190+ Million on Prescription Drugs

A new analysis from the Coalition for Prescription Drug Affordability finds that establishing a Prescription Drug Affordability Board (PDAB) through SB 3496 could save Illinois more than $190 million by automatically adopting Medicare-negotiated drug prices as statewide Upper Payment Limits. The report shows how a PDAB would deliver recurring savings for taxpayers, lower out-of-pocket costs for consumers, and reduce premium growth for employers and families—while maintaining access to life-saving medications. With drug prices continuing to rise and hundreds of thousands of Illinoisans at risk of losing coverage, the PDAB offers a proven, commonsense solution to make prescription drugs more affordable statewide.

Key Findings

  • Illinois could save over $192 million every year on prescription drugs by establishing a Prescription Drug Affordability Board (PDAB) — based on just the first 10 Medicare-negotiated drugs.

  • These savings are a conservative minimum. They do not include private insurance savings, future Medicare-negotiated drugs, or additional high-cost medications a PDAB could regulate.

  • A PDAB would extend Medicare-negotiated prices to all Illinoisans by adopting them as statewide Upper Payment Limits, lowering costs for taxpayers, consumers, and employers.

  • Prescription drug costs are a growing crisis. 77% of Illinois voters worry about affording medications, while rising prices drive higher premiums and out-of-pocket costs.

  • PDABs work. Colorado’s PDAB set its first Upper Payment Limit in 2025, with one drug projected to save up to $32 million annually.

What is a Prescription Drug Affordability Board?

A Prescription Drug Affordability Board (PDAB) is independent body with the authority to evaluate high-cost prescription drugs and set reasonable rates for Illinoisans to pay. 

The Board will review prescription drugs with costs that impact Illinoisans, including high-cost, brand-name medications. The Board will consider a broad range of economic factors when setting appropriate payment rates for reviewed drugs, allowing pharmaceutical manufacturers the opportunity to justify existing drug costs. Once a fair payment rate is determined, the Board sets an upper payment limit that applies to the entire supply chain.

Why Do We Need a PDAB?

Illinoisans are going without essential medication — or rationing it — due to high cost.

According to a 2024 Survey, 31% of Illinois adults reported they have skipped refilling a prescription or not filled one at all due to the cost. No one should have to choose between their medication and other necessities, like rent and groceries. 

We pay more for the same medication that’s available in other countries for a fraction of the cost.

Other countries have rate-setting and negotiation mechanisms in place. Without that in the US, pharmaceutical manufacturers charge whatever they deem the market can bear. As a result, Americans have the highest spending per capita on prescription drugs among high-income countries. Here is a comparison of drug costs for several popular name brand drugs in Canada and the United States.

Drug spending contributes to 1/3 of health insurance premium costs.

High drug costs affect everyone, including people who aren’t on a prescription medication. CareFirst Blue Cross Blue Shield has reported that drug costs were the single largest contributor to overall spending in 2017, accounting for over 33% of total spending. Even when the out-of-pocket costs are manageable, the high cost of prescription drugs burden the entire healthcare system. 

Take Action

Hear from Illinoisans: Drugs Don’t Work If People Can’t Afford Them

Hear from Illinoisans: PDAB in the Papers

FREQUENTLY ASKED QUESTIONS:

ORGANIZATIONS

SIGN OUR RESOLUTION OF SUPPORT FOR A PRESCRIPTION DRUG AFFORDABILITY BOARD

Our Coalition